TY - JOUR
T1 - The Collaborative Ocular Tuberculosis Study (COTS)-1
T2 - A Multinational Review of 165 Patients with Tubercular Anterior Uveitis
AU - Agrawal, Rupesh
AU - Betzler, Bjorn
AU - Testi, Ilaria
AU - Mahajan, Sarakshi
AU - Agarwal, Aniruddha
AU - Gunasekeran, Dinesh Visva
AU - Raje, Dhananjay
AU - Aggarwal, Kanika
AU - Murthy, Somasheila I.
AU - Westcott, Mark
AU - Chee, Soon Phaik
AU - Mccluskey, Peter
AU - Ho, Su Ling
AU - Teoh, Stephen
AU - Cimino, Luca
AU - Biswas, Jyotirmay
AU - Narain, Shishir
AU - Agarwal, Manisha
AU - Mahendradas, Padmamalini
AU - Khairallah, Moncef
AU - Jones, Nicholas
AU - Tugal-Tutkun, Ilknur
AU - Babu, Kalpana
AU - Basu, Soumayava
AU - Carreño, Ester
AU - Lee, Richard
AU - Al-Dhibi, Hassan
AU - Bodaghi, Bahram
AU - Invernizzi, Alessandro
AU - Goldstein, Debra A.
AU - Herbort, Carl P.
AU - Barisani-Asenbauer, Talin
AU - González-López, Julio J.
AU - Androudi, Sofia
AU - Bansal, Reema
AU - Moharana, Bruttendu
AU - Esposti, Simona
AU - Tasiopoulou, Anastasia
AU - Nadarajah, Sengal
AU - Agarwal, Mamta
AU - Abraham, Sharanya
AU - Vala, Ruchi
AU - Singh, Ramandeep
AU - Sharma, Aman
AU - Sharma, Kusum
AU - Zierhut, Manfred
AU - Kon, Onn Min
AU - Cunningham, Emmett T.
AU - Kempen, John H.
AU - Nguyen, Quan Dong
AU - Pavesio, Carlos
AU - Gupta, Vishali
N1 - Publisher Copyright:
© 2020, © 2020 Taylor & Francis Group, LLC.
PY - 2020
Y1 - 2020
N2 - Purpose: The Collaborative Ocular Tuberculosis Study (COTS) Group sought to address the diagnostic uncertainty through retrospective cohort analysis of treatment regimens and therapeutic outcomes for patients with tubercular Anterior Uveitis (TAU) across international centers. Methods: Multicentre retrospective analysis of patients diagnosed with TAU between January 2004 to December 2014 that had a minimum follow-up of 1 year. Results: One hundred and sixty-five patients were included. One hundred and seven subjects received antitubercular therapy (ATT) (n = 107/165; 64.9%) with all the patients receiving topical steroid therapy. Treatment failure was noted in 17 patients (n = 17/165; 10.3%), more frequently described in patients that received ATT (n = 13/107, 12.2%), than those that did not receive ATT (n = 4/58, 6.9%). Conclusion: In this retrospective study, addition of ATT did not have any statistically significant impact on outcome in patients with TAU.
AB - Purpose: The Collaborative Ocular Tuberculosis Study (COTS) Group sought to address the diagnostic uncertainty through retrospective cohort analysis of treatment regimens and therapeutic outcomes for patients with tubercular Anterior Uveitis (TAU) across international centers. Methods: Multicentre retrospective analysis of patients diagnosed with TAU between January 2004 to December 2014 that had a minimum follow-up of 1 year. Results: One hundred and sixty-five patients were included. One hundred and seven subjects received antitubercular therapy (ATT) (n = 107/165; 64.9%) with all the patients receiving topical steroid therapy. Treatment failure was noted in 17 patients (n = 17/165; 10.3%), more frequently described in patients that received ATT (n = 13/107, 12.2%), than those that did not receive ATT (n = 4/58, 6.9%). Conclusion: In this retrospective study, addition of ATT did not have any statistically significant impact on outcome in patients with TAU.
KW - Anti-tubercular therapy
KW - collaborative ocular tuberculosis study (COTS)
KW - ocular tuberculosis
KW - tubercular anterior uveitis
KW - uveitis
UR - http://www.scopus.com/inward/record.url?scp=85087505413&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087505413&partnerID=8YFLogxK
U2 - 10.1080/09273948.2020.1761400
DO - 10.1080/09273948.2020.1761400
M3 - Article
C2 - 32600163
AN - SCOPUS:85087505413
SN - 0927-3948
SP - 1
EP - 10
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
ER -